jjones23	10.1089/adt.2006.040	<http://dx.doi.org/10.1089/adt.2006.040>; rel="canonical", <http://www.liebertpub.com/doi/pdf/10.1089/adt.2006.040>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1089/adt.2006.040"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/olaf-kutsch-235l6ztjgxz15"><j.3:name>Olaf Kutsch</j.3:name><j.3:familyName>Kutsch</j.3:familyName><j.3:givenName>Olaf</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/john-l-hartman-235l6ztjgxz15"><j.3:name>John L. Hartman</j.3:name><j.3:familyName>Hartman</j.3:familyName><j.3:givenName>John L.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/thomas-m-fletcher-235l6ztjgxz15"><j.3:name>Thomas M. Fletcher</j.3:name><j.3:familyName>Fletcher</j.3:familyName><j.3:givenName>Thomas M.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/lucile-white-235l6ztjgxz15"><j.3:name>Lucile White</j.3:name><j.3:familyName>White</j.3:familyName><j.3:givenName>Lucile</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>190</j.2:pageEnd><j.0:publisher>Mary Ann Liebert Inc</j.0:publisher><j.1:startingPage>181</j.1:startingPage><j.1:volume>5</j.1:volume><owl:sameAs rdf:resource="doi:10.1089/adt.2006.040"/><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1540-658X"><owl:sameAs>urn:issn:1540-658X</owl:sameAs><j.1:issn>1557-8127</j.1:issn><j.2:issn>1557-8127</j.2:issn><owl:sameAs>urn:issn:1557-8127</owl:sameAs><j.0:title>ASSAY and Drug Development Technologies</j.0:title><j.1:issn>1540-658X</j.1:issn><j.2:issn>1540-658X</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jennifer-jones-235l6ztjgxz15"><j.3:name>Jennifer Jones</j.3:name><j.3:familyName>Jones</j.3:familyName><j.3:givenName>Jennifer</j.3:givenName></j.3:Person></j.0:creator><j.1:endingPage>190</j.1:endingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/george-m-shaw-235l6ztjgxz15"><j.3:name>George M. Shaw</j.3:name><j.3:familyName>Shaw</j.3:familyName><j.3:givenName>George M.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/joseph-a-maddry-235l6ztjgxz15"><j.3:name>Joseph A. Maddry</j.3:name><j.3:familyName>Maddry</j.3:familyName><j.3:givenName>Joseph A.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>181</j.2:pageStart><j.1:doi>10.1089/adt.2006.040</j.1:doi><j.0:identifier>10.1089/adt.2006.040</j.0:identifier><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/john-rodgers-235l6ztjgxz15"><j.3:name>John Rodgers</j.3:name><j.3:familyName>Rodgers</j.3:familyName><j.3:givenName>John</j.3:givenName></j.3:Person></j.0:creator><j.0:title>High Throughput Drug Screening for Human Immunodeficiency Virus Type 1 Reactivating Compounds</j.0:title><j.2:volume>5</j.2:volume><owl:sameAs rdf:resource="info:doi/10.1089/adt.2006.040"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jori-may-235l6ztjgxz15"><j.3:name>Jori May</j.3:name><j.3:familyName>May</j.3:familyName><j.3:givenName>Jori</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/marintha-heil-235l6ztjgxz15"><j.3:name>Marintha Heil</j.3:name><j.3:familyName>Heil</j.3:familyName><j.3:givenName>Marintha</j.3:givenName></j.3:Person></j.0:creator><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2007-04</j.0:date><j.2:doi>10.1089/adt.2006.040</j.2:doi></rdf:Description></rdf:RDF>
